Abstract

Introduction Early prediction of drug toxicity remains challenging in pre-clinical toxicological studies. Especially on the protein level there is a lack of methods enabling discovery and validation of predictive biomarker signatures in animal or cell-based models exposed to toxic insults. Multiple reaction monitoring (MRM), a massspectrometric approach, enables monitoring of up to 100 proteins in a single measurement with high specificity and accuracy if optimal assays are available.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call